U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
SAN FRANCISCO, April 19, 2017 -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3, 2017. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 348-0016 for domestic callers or (213) 358-0876 for international callers, using Conference ID: 93436882. A live and archived webcast of the event will be available on the “Investors” section of the company’s website at: www.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
Investor Relations Contact: Lynn Pieper Lewis or Leigh Salvo (415) 937-5404 [email protected] Media Contact Aaron Murphy (415) 229-3331 [email protected]
